Effects (MACE and bleeding events) of ticagrelor combined with omeprazole on patients with acute myocardial infarction undergoing primary PCI

Effects (MACE and bleeding events) of ticagrelor combined with omeprazole on patients with acute myocardial infarction undergoing primary PCI

Background: This study aimed to investigate the effect of ticagrelor combined with omeprazole on patients with acute myocardial infarction (AMI) undergoing primary percutaneous coronary intervention (PCI). Methods: Eighty-six patients with AMI who underwent primary PCI in Xinxiang Central Hospital b...

Full description

Bibliographic Details
Main Authors:	Fucheng Zhang, Shuhong Su, Yuyan Hou, Lipei Zhao, Zhifang Wang, Fen Liu, Fengli Wu, Li Zhang
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	Hellenic Journal of Cardiology
Subjects:	ticagrelor omeprazole major adverse cardiac events bleeding events acute myocardial infarction
Online Access:	http://www.sciencedirect.com/science/article/pii/S1109966618305001

Similar Items

Combined with ticagrelor, 50 mg aspirin daily can reduce bleeding events without increasing ischemic risk compared with 75–100 mg aspirin daily in coronary artery disease patients: insights from the TIFU (Ticagrelor in Fuwai Hospital) study
by: Jiannan Li, et al.
Published: (2020-08-01)

Ticagrelor and omeprazole: A desirable combination in post MI patients?
by: Dimitrios Alexopoulos
Published: (2020-09-01)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
by: Bin YANG, et al.
Published: (2018-07-01)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
by: Viviana Laredo, et al.
Published: (2020-05-01)

Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction
by: Giulia Magnani, et al.
Published: (2021-02-01)

Intravenous form of omeprazole will be replaced by oral form in patients with ulcer bleeding
by: A.V. Savustyanenko
Published: (2014-11-01)

Comparison of In-Hospital Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction Treated with Ticagrelor or Clopidogrel in the Emergency Department: A Propensity Score Matched Retrospective Cohort Study
by: Po-Yao Huang, et al.
Published: (2023-08-01)

Ticagrelor monotherapy after a short course of dual antiplatelet therapy with ticagrelor plus aspirin following percutaneous coronary intervention in patients with versus without diabetes mellitus: a meta-analysis of randomized trials
by: Chen Ning, et al.
Published: (2024-03-01)

Efficacy and safety of empiric treatment with omeprazole continuous infusion in critically ill children with gastrointestinal bleeding
by: Khalid W. Taher, et al.
Published: (2024-04-01)

Adverse reaction signals mining and hemorrhagic signals comparison of ticagrelor and clopidogrel: A pharmacovigilance study based on FAERS
by: Shu Tang, et al.
Published: (2022-10-01)

A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor
by: Yunyan Pan, et al.
Published: (2024-04-01)

Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: He-Yang Wang, et al.
Published: (2018-01-01)

Temporal Trends of Bleeding Episodes during Half- vs. Standard-Dose Ticagrelor in Acute Coronary Syndrome Patients with Low Platelet Reactivity: A Randomized BLEEDING-ACS Trial
by: Laeun Kim, et al.
Published: (2021-03-01)

Bleeding Severity in Percutaneous Coronary Intervention (PCI) and Its Impact on Short-Term Clinical Outcomes
by: Shashank Murali, et al.
Published: (2020-05-01)

Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction?
by: Anke C. Fender, et al.
Published: (2020-04-01)

Increased Susceptibility for Thromboembolic Events versus High Bleeding Risk Associated with COVID-19
by: Cristina Tudoran, et al.
Published: (2022-08-01)

Efficacy and safety of ticagrelor versus clopidogrel with different dosages in acute coronary syndrome patients with high GRACE and CRUSADE scores
by: Peng Xiao, et al.
Published: (2021-05-01)

Cost analysis of dual antiplatelet therapy with prasugrel and ticagrelor in patients with acute coronary syndrome after percutaneous coronary intervention
by: I. N. Dyakov, et al.
Published: (2020-09-01)

Efficacy and safety of different ticagrelor regimens versus clopidogrel in patients with coronary artery disease: a retrospective multicenter study (SUPERIOR)
by: Jing Shi, et al.
Published: (2021-01-01)

Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH
by: Iida Hiroshi, et al.
Published: (2012-03-01)

Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis
by: Pravesh Kumar Bundhun, et al.
Published: (2018-05-01)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
by: Candice Volney, et al.
Published: (2019-07-01)

Ticagrelor regulates the differentiation of MDSCs after acute myocardial infarction to reduce cardiac injury
by: Zijian Huang, et al.
Published: (2024-03-01)

Prevalence of adverse events during ticagrelor versus clopidogrel treatment and its association with premature discontinuation of dual antiplatelet therapy in East Asian patients with acute coronary syndrome
by: Min Gyu Kang, et al.
Published: (2022-12-01)

Prescripción, dispensación y sustitución de recetas de omeprazol Prescription, dispensation and sustitution of prescription forms of omeprazole
by: M. B. Vaquero
Published: (2003-07-01)

Thromboembolic and Bleeding Events in Transthyretin Amyloidosis and Coagulation System Abnormalities: A Review
by: Angela Napolitano, et al.
Published: (2023-10-01)

Influence of apelin-12 on troponin levels and the rate of MACE in STEMI patients
by: Xhevdet Krasniqi, et al.
Published: (2017-07-01)

Ticagrelor in patients with stable coronary artery disease: a role in improving prognosis
by: T. N. Novikova
Published: (2020-09-01)

Clinical outcomes with the use of ticagrelor or clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction – A prospective observational study
by: Bibek Agarwal, et al.
Published: (2022-01-01)

Comparative Study Between the Efficacies of Vonoprazan Versus Omeprazole in Patients with Gastroesophageal Reflux Disease
by: Mohammed Mahdi, et al.
Published: (2023-01-01)

Avaliação do efeito antiparasitário do omeprazol na prevenção do desenvolvimento de lesões cutâneas em hamsters infectados por Leishmania brasiliensis Evaluation of omeprazole's antiparasitary effect preventing the development of cutaneous lesions due to Leishmania brasiliensis in hamsters
by: Hélio Amante Miot, et al.
Published: (2005-12-01)

Ticagrelor hemorrhagic safety in patients with acute coronary syndrome with ST-segment elevation received thrombolytic therapy in daily clinical practice: 30-day observation results
by: A. V. Bocharov, et al.
Published: (2020-05-01)

Superiority of bivalirudin over heparin anticoagulation therapy for extracorporeal membrane oxygenation? Too early to draw conclusions
by: Jie Gu, et al.
Published: (2023-02-01)

Investigation of omeprazole stability in oral suspensions for pediatric use prepared extemporaneously from omeprazole capsules
by: Milić Jela, et al.
Published: (2017-01-01)

Sociodemographic and clinical profile of elderly people chronic users of omeprazole attending the basic health network / Perfil sociodemográfico e clínico de idosos usuários crônicos de omeprazol na rede básica de saúde
by: Christiane de Fátima Colet, et al.
Published: (2019-07-01)

Comparison of clopidogrel and ticagrelor in treating acute coronary syndrome undergoing PCI: A systematic review and meta-analysis
by: Jing Yang, et al.
Published: (2024-03-01)

Comparing the effectiveness and safety of dual antiplatelet with ticagrelor or clopidogrel in elderly Asian patients with acute myocardial infraction
by: Jong-Shiuan Yeh, et al.
Published: (2023-03-01)

Cytoprotective Actions of Omeprazole in Indomethacin – Induced Gastric Mucosal Injury in Rats.
by: Mohammed J. Manna, et al.
Published: (2010-04-01)

Omeprazole-induced galactorrhea in kidney transplant patients—a case report
by: Choki Dorji, et al.
Published: (2022-03-01)

Relevancia clínica de la interacción clopidogrel y omeprazol: revisión sistemática Clinical relevance of clopidogrel and omeprazole interaction: systematic review
by: Héctor Holguín, et al.
Published: (2012-01-01)